Human Serum Proteins and Susceptibility of Acinetobacter baumannii to Cefiderocol: Role of Iron Transport
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human Serum Proteins and Susceptibility of Acinetobacter baumannii to Cefiderocol: Role of Iron Transport
Authors
Keywords
-
Journal
Biomedicines
Volume 10, Issue 3, Pages 600
Publisher
MDPI AG
Online
2022-03-03
DOI
10.3390/biomedicines10030600
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolution of Cefiderocol Non-Susceptibility in Pseudomonas aeruginosa in a Patient Without Previous Exposure to the Antibiotic
- (2021) Ana Paula Streling et al. CLINICAL INFECTIOUS DISEASES
- Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections
- (2021) Katie A Parsels et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cerebrospinal fluid (CSF) augments metabolism and virulence expression factors in Acinetobacter baumannii
- (2021) Jasmine Martinez et al. Scientific Reports
- Pathogenesis of Gram-Negative Bacteremia
- (2021) Caitlyn L. Holmes et al. CLINICAL MICROBIOLOGY REVIEWS
- Human Pleural Fluid and Human Serum Albumin Modulate the Behavior of a Hypervirulent and Multidrug-Resistant (MDR) Acinetobacter baumannii Representative Strain
- (2021) Camila Pimentel et al. Pathogens
- Contribution of PER-Type and NDM-Type β-Lactamases to Cefiderocol Resistance in Acinetobacter baumannii
- (2021) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Perspectives on Antimicrobial Agents: Cefiderocol
- (2021) Erin K. McCreary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interplay between Meropenem and Human Serum Albumin on Expression of Carbapenem Resistance Genes and Natural Competence in Acinetobacter baumannii
- (2021) Casin Le et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA
- (2021) Sabrina Klein et al. CLINICAL INFECTIOUS DISEASES
- Cefiderocol Activity Against Clinical Pseudomonas aeruginosa Isolates Exhibiting Ceftolozane-Tazobactam Resistance
- (2021) Patricia J Simner et al. Open Forum Infectious Diseases
- Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives
- (2021) Davide Fiore Bavaro et al. Antibiotics-Basel
- Interaction of Acinetobacter baumannii with Human Serum Albumin: Does the Host Determines the Outcome?
- (2021) Camila Pimentel et al. Antibiotics-Basel
- Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance
- (2021) Christina König et al. Antibiotics-Basel
- Defining Baseline Mechanisms of Cefiderocol Resistance in the Enterobacterales
- (2021) Patricia J. Simner et al. Microbial Drug Resistance
- In vitro activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex isolates collected globally from 2016-2017
- (2020) Sarah M. McLeod et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Distinct mechanisms of dissemination of NDM-1 metallo- β-lactamase in Acinetobacter spp. in Argentina
- (2020) Mark D. Adams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New treatment options for multiresistant gram negatives
- (2020) David L. Paterson et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Impact of Intrinsic Resistance Mechanisms on Potency of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii
- (2020) Olga Lomovskaya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human Serum Albumin Facilitates Heme-Iron Utilization by Fungi
- (2020) Mariel Pinsky et al. mBio
- Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace
- (2020) Maria Soledad Ramirez et al. Biomolecules
- Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety
- (2020) Young Ran Lee et al. CLINICAL DRUG INVESTIGATION
- Cefiderocol Resistance in Acinetobacter baumannii: Roles of β-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3
- (2020) Saquib Malik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
- (2020) Richard G Wunderink et al. LANCET INFECTIOUS DISEASES
- Acinetobacter baumannii can use multiple siderophores for iron acquisition, but only acinetobactin is required for virulence
- (2020) Jessica R. Sheldon et al. PLoS Pathogens
- Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively- and pan-resistant Acinetobacter baumannii
- (2020) A. Oliva et al. Journal of Global Antimicrobial Resistance
- Characterisation of ST25 NDM-1-producing Acinetobacter spp. strains leading the increase in NDM-1 emergence in Argentina
- (2020) Deja Rodgers et al. Journal of Global Antimicrobial Resistance
- Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens
- (2019) Ilias Karaiskos et al. Expert Opinion on Drug Metabolism & Toxicology
- Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
- (2019) Melissa D. Barnes et al. mBio
- Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
- (2019) George G. Zhanel et al. DRUGS
- Management of carbapenem-resistant Enterobacteriaceae infections
- (2019) E. Durante-Mangoni et al. CLINICAL MICROBIOLOGY AND INFECTION
- New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
- (2019) Shio-Shin Jean et al. DRUGS
- Identification of Potential Virulence Factors in the Model Strain Acinetobacter baumannii A118
- (2019) Maria S. Ramirez et al. Frontiers in Microbiology
- Human Pleural Fluid Elicits Pyruvate and Phenylalanine Metabolism in Acinetobacter baumannii to Enhance Cytotoxicity and Immune Evasion
- (2019) Nyah Rodman et al. Frontiers in Microbiology
- The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
- (2019) Ilias Karaiskos et al. Frontiers in Public Health
- Efficacy of Humanized Cefiderocol Exposure Is Unaltered by Host Iron Overload in the Thigh Infection Model
- (2019) James M. Kidd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of Neutropenic Murine Models of Iron Overload and Depletion To Study the Efficacy of Siderophore-Antibiotic Conjugates
- (2019) James M. Kidd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin
- (2019) Takafumi Sato et al. CLINICAL INFECTIOUS DISEASES
- Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens
- (2019) Robert A Bonomo CLINICAL INFECTIOUS DISEASES
- Human pleural fluid triggers global changes in the transcriptional landscape of Acinetobacter baumannii as an adaptive response to stress
- (2019) Jasmine Martinez et al. Scientific Reports
- TonB-Dependent Receptor Repertoire of Pseudomonas aeruginosa for Uptake of Siderophore-Drug Conjugates
- (2018) Alexandre Luscher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cefiderocol (S-649266), A new siderophore cephalosporin exhibiting potent activities against Pseudomonas aeruginosa and other gram-negative pathogens including multi-drug resistant bacteria: Structure activity relationship
- (2018) Toshiaki Aoki et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6/Hjv/Smad signaling
- (2018) Carine Fillebeen et al. BLOOD
- Human serum albumin alters specific genes that can play a role in survival and persistence in Acinetobacter baumannii
- (2018) Brettni Quinn et al. Scientific Reports
- ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases
- (2018) Michael R. Jacobs et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
- (2018) Burcu Isler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemases: The never-ending story
- (2018) Luis Martínez-Martínez ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Preacinetobactin not acinetobactin is essential for iron uptake by the BauA transporter of the pathogen Acinetobacter baumannii
- (2018) Lucile Moynié et al. eLife
- Proteomic analysis of iron-regulated membrane proteins identify FhuE receptor as a target to inhibit siderophore-mediated iron acquisition in Acinetobacter baumannii
- (2018) Vishvanath Tiwari et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
- (2017) Thomas F. Durand-Réville et al. Nature Microbiology
- Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity againstPseudomonas aeruginosa
- (2016) Akinobu Ito et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Deadly Impact of Extreme Drug Resistance in Acinetobacter baumannii*
- (2014) Brad Spellberg et al. CRITICAL CARE MEDICINE
- AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments
- (2014) A. C. Jacobs et al. mBio
- Involvement of Fe Uptake Systems and AmpC β-Lactamase in Susceptibility to the Siderophore Monosulfactam BAL30072 in Pseudomonas aeruginosa
- (2013) Christian van Delden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Ethanol on Differential Protein Production and Expression of Potential Virulence Functions in the Opportunistic Pathogen Acinetobacter baumannii
- (2012) Chika C. Nwugo et al. PLoS One
- Horizontal Gene Transfer and Assortative Recombination within the Acinetobacter baumannii Clinical Population Provide Genetic Diversity at the Single carO Gene, Encoding a Major Outer Membrane Protein Channel
- (2011) M. A. Mussi et al. JOURNAL OF BACTERIOLOGY
- TonB-Dependent Transporters: Regulation, Structure, and Function
- (2010) Nicholas Noinaj et al. Annual Review of Microbiology
- Genomewide Analysis of Divergence of Antibiotic Resistance Determinants in Closely Related Isolates of Acinetobacter baumannii
- (2010) M. D. Adams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Control measures for Acinetobacter baumannii: a survey of Spanish hospitals
- (2010) Lola García-Ortega et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates
- (2010) Luísa C.S. Antunes et al. RESEARCH IN MICROBIOLOGY
- Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii
- (2009) Daniel L. Zimbler et al. BIOMETALS
- Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
- (2008) M. D. Adams et al. JOURNAL OF BACTERIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now